STIL Stille AB (publ)
Stille AB (publ) develops, manufactures, and distributes medtech products in Sweden, Germany, the United Kingdom, Switzerland, North America, the United States, and internationally. It operates through the Surgical Instruments and Surgical Tables segments. The Surgical Instruments segment offers surgical scissors, including SuperCut, eye, blepharoplasty, operating, vascular, tenotomy, and face-lift scissors; colon, gall duct, multi-purpose, tangential occlusion, peripheral vascular, and anastomosis clamps; skin and nerve hooks, retractors, rib spreaders, self-retaining and trachea retractors, and nasal specula; and dressing, diathermy, knot-holding, tissue, iris, dura, and vascular forceps under the STILLE, Fehling, S&T, and Surgical Holdings brands. Its Surgical Tables segment provides C-arm tables, which are surgical tables used in advanced imaging, cardiac electrophysiology, cardiovascular and vascular, gastrointestinal and abdominal, interventional radiology, neuro/spine, pain management, and pulmonary under the imagiQ and MedStone brands. The company also offers instrument care education, repair and maintenance, and inspection services. Stille AB (publ) was founded in 1841 and is headquartered in Torshälla, Sweden.…
Industry Peers
Medical Instruments & SuppliesKey Statistics
About Stille (STO: STIL)
›
Stille (STO: STIL) is listed on Nasdaq Stockholm, where its shares trade in SEK. It belongs to the Medical Instruments & Supplies industry, part of the Healthcare sector, and reports about 239 employees.
The shares were at 250.50 SEK on 19 November 2026, up 42.7% over 52 weeks. Its 52-week range is 143.00 SEK to 283.00 SEK: the price is 11.5% below the high and 75.2% above the low.
At a market capitalisation of 2.25B SEK, it trades at 23.0 times trailing earnings and 20.6 times forward earnings. The median trailing P/E of its 19 largest Medical Instruments & Supplies peers is 49.2, a discount of 53% for STIL.
Stille reports return on equity of 7.9%, an operating margin of 15.7% and revenue up 22.9% year over year.
It holds more cash than debt, a net cash position of 170.71M SEK. Its Piotroski F-score is 4 out of 9, an average reading of its financial health. 2 analysts cover the stock; their mean price target of 298.00 SEK is 19.0% above the current price.